@article{d04202eeaabd4ad1a0d3527b74f03f5a,
title = "Special report on the 2007 adult and pediatric Position Development Conferences of the International Society for Clinical Densitometry",
abstract = "The International Society for Clinical Densitometry (ISCD) conducts Position Development Conferences (PDCs) for the purpose of establishing standards and guidelines in the field of bone densitometry. Topics for consideration are selected according to clinical relevance, a perceived need for standardization, and the likelihood of achieving agreement. Questions regarding nomenclature, indications, acquisition, analysis, quality control, interpretation, and reporting of bone density tests for each topic area are assigned to task forces for a comprehensive review of the scientific literature. The findings of the review and recommendations are then presented to an international panel of experts at the PDC. The expert panel votes on potential Official Positions for appropriateness, necessity, quality of the evidence, strength of the recommendation, and applicability (worldwide or variable according to local requirements). Recommendations that are approved by the ISCD Board of Directors become Official Positions. The first Pediatric PDC was 20-21 June 2007 in Montreal, QC, Canada. The most recent Adult PDC was held 20-22 July 2007, in Lansdowne, VA, USA. This Special Report summarizes the methodology of the ISCD PDCs and presents selected Official Positions of general interest.",
keywords = "BMD testing, DXA, Guidelines, ISCD, Official positions, Osteoporosis, Recommendations, Standards",
author = "Lewiecki, {E. M.} and Gordon, {C. M.} and S. Baim and N. Binkley and Bilezikian, {J. P.} and Kendler, {D. L.} and Hans, {D. B.} and S. Silverman and Bishop, {N. J.} and Leonard, {M. B.} and Bianchi, {M. L.} and Kalkwarf, {H. J.} and Langman, {C. B.} and H. Plotkin and F. Rauch and Zemel, {B. S.}",
note = "Funding Information: S.L. Silverman: consultant for Merck, P&G, Wyeth, Roche, Novartis; officer or board member for Compumed; research funding from Novartis, Lilly, Wyeth, Roche, P&G, Merck; speaker for Lilly, Merck, P&G, Roche. Funding Information: D.L. Kendler: consultant for Merck, Pfizer, Servier, Lilly, Novartis, Amgen; educational grants from Merck, Pfizer, Servier, Lilly, Novartis, Amgen, P&G; honoraria from Merck, Pfizer, Servier, Lilly, Novartis, Amgen, P&G; research funding from Merck, Pfizer, Servier, Lilly, Novartis, Amgen, P&H, Takeda, Wyeth, Zelos, J&J; speaker for Merck, Servier, Lilly, Novartis, Amgen, P&G. Funding Information: M.-L. Bianchi: educational grants from Telethon; VILDM research funding from Telethon. Funding Information: E.M. Lewiecki: committee chair for ISCD; educational grants from P&G, Amgen, Novartis; honoraria from Merck, Lilly, P&G, Roche, GSK, Novartis; officer or board member for ISCD; ownership interest in GE Healthcare, P&G; research funding from Merck, P&G, Roche, Lilly, Amgen, Novartis; speaker for Merck, Lilly, P&G, Roche, GSK, Novartis. Funding Information: C.B. Langman: director of institutional research for Amgen: research funding from Amgen. ",
year = "2008",
month = oct,
doi = "10.1007/s00198-008-0689-9",
language = "English (US)",
volume = "19",
pages = "1369--1378",
journal = "Osteoporosis International",
issn = "0937-941X",
publisher = "Springer London",
number = "10",
}
